Medipharm Labs Corp T.LABS

Volume/RSU’s/insiders.

[alleyesonme]

Looking like volume may be related to the award of RSU's and the selling of a portion to cover tax obligations...much like last year...sedi should have some new filings in the coming business days..

[alleyesonme]

RSU's granted early...execs/board granted RSU's December 09, 2024...scheduled to vest December 22nd...4 tranches over 2 years every 6 months....info is now up on sedi..most sold 50% of granted RSU's..net accumulation.....very interesting...why would the last tranche be awarded 13 days early?...what's going on for this to happen?...what's another 13days?...IMO...buyout offer

[alleyesonme]

So what happens to your vested stock options when a company is bought? Typically, when a company is bought out, the buyer will either: Cash out vested stock options Substitute the target company’s grant with shares of the acquiring company’s stock Cancel the grant.https://darrowwealthmanagement.com/blog/asset-management-employee-stock-options-after-acquisition/

[NoRiskNoReward]

Employees may vest their restricted stock units (RSUs) early for a number of reasons, including: Mergers and acquisitions Some agreements may accelerate vesting when there is a change in control, ensuring that employees receive the full value of their RSUs. 

[alleyesonme]

Yup, it's the #1 reason RSU's vest early. MD&A is a topic every quarter..Pidduck talks about how undervalued the Corp is at the beginning of the year...a takeover bid could include a pause on RSU issuance while the bid is in process...they must be worried about that..otherwise they'd wait a mere 13 days..this is strong evidence a takeover bid is imminent...what's the price

[NoRiskNoReward]

Yeah it's starting to look like a takeover is very soon. I don't see this company being sold for less then 50 cent a share. It's been a long road for most shareholders, hopefully it's been worth the wait ! 

[Solid1]

Medipharm Labs never disclosed its pharma partners, and the NDA and ANDA were never disclosed, and all the studies they conducted with their pharma partners were never disclosed. Then an acquisition was made under false pretenses, which led to a lawsuit. I can't imagine that happening, and if there are enough investors, it would have to be investigated to see if it was a cartel. 

[Solid1]

For which illnesses/therapies? What is the name of the partner? How big could the market be? Absolutely nothing has been announced, as Pidduck themselves said... that they want to keep a low profile and not disclose the information 

[alleyesonme]

It's called a non disclosure agreement(NDA) commonplace especially in the pharmaceutical industry..disclosure to the shareholder Looks exactly what it has been...global pharmaceutical partners in pursuit of NDA's, ANDA's, 505b2....absolutely proper disclosure..no chance this would be an issue when the offer comes forward...hopefully it will be soo good you won't be upset...the only

[Solid1]

Unfortunately no. With Pidduck's statement in Q3 2022 alone, you could nail Medipharm Labs to the wall.... If it came to a secret takeover... that's a legal term by the way... Takeover under deception